HKEX:799 stock news
This page provides real-time market news, earnings updates, and company announcements related to IGG, Inc. (HKEX:799).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-20 16:47 HKT
Long Term Data Published in JAMA Neurology Demonstrate Sustained Efficacy and Consistent Safety of BRIUMVI in Relapsing Multiple Sclerosis
Finviz2026-02-17 12:33:43
Long Term Data Published in JAMA Neurology Demonstrate Sustained Efficacy and Consistent Safety of BRIUMVI in Relapsing Multiple Sclerosis
Finviz2026-02-17 12:33:43
Immuron Reports HY26 Results and Strategic Reset
Finviz2026-02-25 11:03:09
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods IBS Therapy
Finviz2026-02-26 13:21:55
Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion
Finviz2026-03-02 13:03:56
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
Finviz2026-03-03 21:18:44
Immunovant, Inc. (IMVT) Analysts Raise Price Targets Following Q3 Earnings Update
Finviz2026-03-04 07:33:08
New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis
Finviz2026-03-28 19:03:43
Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)
Finviz2026-04-02 09:03:48
Roivant Announces Expansion of Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP) and Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)
Finviz2026-04-02 09:03:48
Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion
Finviz2026-03-02 13:03:56
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
Finviz2026-03-03 21:18:44
Immunovant, Inc. (IMVT) Analysts Raise Price Targets Following Q3 Earnings Update
Finviz2026-03-04 07:33:08
New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis
Finviz2026-03-28 19:03:43
Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)
Finviz2026-04-02 09:03:48
Roivant Announces Expansion of Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP) and Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)
Finviz2026-04-02 09:03:48
HKEX:799 stock price change
On the last trading day, HKEX:799 stock closed at 3.11 HKD, with a price change of 0.65% for the day.
Trade stock perpsHKEX:799 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more